Financial Snapshot

Revenue
$97.73M
TTM
Gross Margin
58.4%
TTM
Net Earnings
-$14.24M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
205.67%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$65.32M
Q3 2024
Cash
Q3 2024
P/E
-6.922
Nov 29, 2024 EST
Free Cash Flow
$235.0K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $112.3M $113.3M $118.9M $102.1M $116.2M $120.8M $77.41M $104.5M $108.7M $108.7M $105.2M $111.2M $108.9M $108.2M $85.77M $88.00M $83.40M $76.20M $67.40M $64.70M $52.00M $57.40M $40.90M $30.60M $26.20M $12.20M $11.50M $8.200M
YoY Change -0.96% -4.68% 16.46% -12.12% -3.81% 56.02% -25.94% -3.81% 0.0% 3.32% -5.4% 2.12% 0.63% 26.12% -2.53% 5.52% 9.45% 13.06% 4.17% 24.42% -9.41% 40.34% 33.66% 16.79% 114.75% 6.09% 40.24%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $112.3M $113.3M $118.9M $102.1M $116.2M $120.8M $77.41M $104.5M $108.7M $108.7M $105.2M $111.2M $108.9M $108.2M $85.77M $88.00M $83.40M $76.20M $67.40M $64.70M $52.00M $57.40M $40.90M $30.60M $26.20M $12.20M $11.50M $8.200M
Cost Of Revenue $46.18M $52.52M $51.25M $44.06M $51.85M $57.59M $38.24M $56.11M $59.94M $59.32M $57.48M $58.83M $58.67M $56.37M $44.09M $45.90M $43.20M $38.10M $34.20M $33.30M $27.40M $28.80M $20.20M $16.10M $13.50M $5.400M $5.100M $4.100M
Gross Profit $66.07M $60.82M $67.65M $58.04M $64.32M $63.18M $39.17M $48.42M $48.72M $49.34M $47.70M $52.34M $50.19M $51.81M $41.68M $42.20M $40.20M $38.10M $33.30M $31.40M $24.60M $28.60M $20.70M $14.50M $12.60M $6.800M $6.300M $4.100M
Gross Profit Margin 58.86% 53.66% 56.9% 56.85% 55.37% 52.31% 50.6% 46.32% 44.84% 45.41% 45.35% 47.08% 46.11% 47.89% 48.6% 47.95% 48.2% 50.0% 49.41% 48.53% 47.31% 49.83% 50.61% 47.39% 48.09% 55.74% 54.78% 50.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Selling, General & Admin $46.89M $49.53M $48.95M $43.43M $46.02M $45.83M $32.61M $41.44M $40.41M $35.05M $35.22M $36.41M $34.54M $34.06M $26.87M $26.10M $25.20M $24.50M $20.70M $18.50M $14.50M $18.90M $14.50M $22.80M $9.900M $4.000M $4.000M $2.900M
YoY Change -5.34% 1.2% 12.72% -5.65% 0.43% 40.54% -21.31% 2.54% 15.29% -0.47% -3.27% 5.41% 1.41% 26.74% 2.96% 3.57% 2.86% 18.36% 11.89% 27.59% -23.28% 30.34% -36.4% 130.3% 147.5% 0.0% 37.93%
% of Gross Profit 70.97% 81.44% 72.35% 74.82% 71.55% 72.53% 83.24% 85.59% 82.94% 71.03% 73.84% 69.56% 68.81% 65.74% 64.47% 61.85% 62.69% 64.3% 62.16% 58.92% 58.94% 66.08% 70.05% 157.24% 78.57% 58.82% 63.49% 70.73%
Research & Development $11.76M $12.33M $10.80M $8.685M $10.72M $10.99M $5.645M $5.392M $6.420M $4.880M $4.154M $4.344M $3.874M $4.669M $4.396M $4.000M $3.700M $3.200M $3.000M $3.000M $2.000M $4.100M $3.200M $1.500M $1.200M $300.0K $200.0K $200.0K
YoY Change -4.58% 14.17% 24.34% -18.95% -2.48% 94.65% 4.69% -16.01% 31.56% 17.48% -4.37% 12.13% -17.03% 6.21% 9.9% 8.11% 15.63% 6.67% 0.0% 50.0% -51.22% 28.12% 113.33% 25.0% 300.0% 50.0% 0.0%
% of Gross Profit 17.81% 20.27% 15.96% 14.96% 16.66% 17.39% 14.41% 11.14% 13.18% 9.89% 8.71% 8.3% 7.72% 9.01% 10.55% 9.48% 9.2% 8.4% 9.01% 9.55% 8.13% 14.34% 15.46% 10.34% 9.52% 4.41% 3.17% 4.88%
Depreciation & Amortization $1.500M $1.453M $1.781M $1.922M $1.987M $2.423M $1.317M $1.532M $1.745M $1.253M $1.298M $4.206M $4.329M $3.917M $1.204M $3.350M $3.450M $3.230M $4.930M $6.240M $5.280M $3.010M $2.970M $1.330M $1.190M $710.0K $460.0K $0.00
YoY Change 3.23% -18.42% -7.34% -3.27% -17.99% 83.98% -14.03% -12.21% 39.27% -3.47% -69.14% -2.84% 10.52% 225.33% -64.06% -2.9% 6.81% -34.48% -20.99% 18.18% 75.42% 1.35% 123.31% 11.76% 67.61% 54.35%
% of Gross Profit 2.27% 2.39% 2.63% 3.31% 3.09% 3.84% 3.36% 3.16% 3.58% 2.54% 2.72% 8.04% 8.62% 7.56% 2.89% 7.94% 8.58% 8.48% 14.8% 19.87% 21.46% 10.52% 14.35% 9.17% 9.44% 10.44% 7.3% 0.0%
Operating Expenses $64.18M $67.75M $65.59M $57.82M $63.95M $62.20M $39.81M $51.41M $50.44M $42.73M $46.16M $44.51M $41.79M $41.59M $33.63M $32.10M $30.70M $29.40M $25.30M $23.10M $17.50M $24.60M $19.40M $24.90M $11.50M $4.300M $4.200M $3.100M
YoY Change -5.28% 3.3% 13.43% -9.58% 2.81% 56.25% -22.58% 1.94% 18.05% -7.44% 3.7% 6.52% 0.48% 23.67% 4.76% 4.56% 4.42% 16.21% 9.52% 32.0% -28.86% 26.8% -22.09% 116.52% 167.44% 2.38% 35.48%
Operating Profit $1.894M -$6.933M $2.066M $221.0K $377.0K $984.0K -$635.0K -$2.997M -$1.713M $6.618M $1.537M $7.830M $8.405M $10.22M $8.055M $10.10M $9.500M $8.700M $8.000M $8.300M $7.100M $4.000M $1.300M -$10.40M $1.100M $2.500M $2.100M $1.000M
YoY Change -127.32% -435.58% 834.84% -41.38% -61.69% -254.96% -78.81% 74.96% -125.88% 330.58% -80.37% -6.84% -17.74% 26.85% -20.25% 6.32% 9.2% 8.75% -3.61% 16.9% 77.5% 207.69% -112.5% -1045.45% -56.0% 19.05% 110.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Interest Expense -$3.591M -$2.548M -$1.540M -$4.831M -$5.410M $5.367M $713.0K $639.0K $846.0K $990.0K $955.0K $584.0K $752.0K $677.0K $277.0K $0.00 $0.00 -$200.0K -$700.0K -$600.0K -$200.0K $700.0K $1.300M -$38.00M -$30.40M -$1.600M -$400.0K -$100.0K
YoY Change 40.93% 65.45% -68.12% -10.7% -200.8% 652.73% 11.58% -24.47% -14.55% 3.66% 63.53% -22.34% 11.08% 144.4% -100.0% -71.43% 16.67% 200.0% -128.57% -46.15% -103.42% 25.0% 1800.0% 300.0% 300.0%
% of Operating Profit -189.6% -74.54% -2185.97% -1435.01% 545.43% 14.96% 62.13% 7.46% 8.95% 6.63% 3.44% 0.0% 0.0% -2.3% -8.75% -7.23% -2.82% 17.5% 100.0% -2763.64% -64.0% -19.05% -10.0%
Other Income/Expense, Net -$4.450M -$2.246M -$2.206M -$7.513M -$5.879M -$8.959M -$1.986M -$81.00K -$1.895M -$2.201M -$1.102M -$938.0K -$1.537M -$655.0K $1.757M -$900.0K $0.00 -$100.0K $0.00 -$100.0K -$800.0K $0.00 $0.00 -$100.0K -$100.0K $0.00 $100.0K $0.00
YoY Change 98.13% 1.81% -70.64% 27.79% -34.38% 351.11% 2351.85% -95.73% -13.9% 99.73% 17.48% -38.97% 134.66% -137.28% -295.22% -100.0% -100.0% -87.5% -100.0% 0.0% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Pretax Income -$2.556M -$9.179M -$140.0K -$7.292M -$5.616M -$9.034M -$3.662M -$3.107M -$3.331M $1.846M -$2.549M $681.0K $339.0K $2.719M $9.812M $7.700M $9.600M $8.400M $7.100M $7.600M $6.200M $2.400M -$3.400M -$48.50M -$29.30M $900.0K $1.800M $900.0K
YoY Change -72.15% 6456.43% -98.08% 29.84% -37.83% 146.7% 17.86% -6.72% -280.44% -172.42% -474.3% 100.88% -87.53% -72.29% 27.43% -19.79% 14.29% 18.31% -6.58% 22.58% 158.33% -170.59% -92.99% 65.53% -3355.56% -50.0% 100.0%
Income Tax $859.0K $337.0K $148.0K $518.0K -$815.0K -$3.676M -$605.0K $1.229M $15.43M $2.062M -$288.0K $2.398M $1.579M -$9.452M $2.673M $2.200M $2.000M $1.800M $900.0K $3.100M $2.500M $1.600M $1.800M $1.400M $100.0K $800.0K $700.0K $400.0K
% Of Pretax Income 111.7% 352.13% 465.78% -347.63% 27.24% 28.57% 20.83% 21.43% 12.68% 40.79% 40.32% 66.67% 88.89% 38.89% 44.44%
Net Earnings -$3.415M -$9.516M -$288.0K -$7.810M -$4.687M -$2.922M -$865.0K -$4.307M -$19.04M $2.355M -$1.830M $2.370M $3.812M $19.02M $7.233M $1.700M -$1.400M -$2.300M -$31.90M $2.300M $4.300M $700.0K -$5.200M -$49.90M -$29.40M $100.0K $1.100M $500.0K
YoY Change -64.11% 3204.17% -96.31% 66.63% 60.4% 237.8% -79.92% -77.38% -908.45% -228.69% -177.22% -37.83% -79.95% 162.89% 325.47% -221.43% -39.13% -92.79% -1486.96% -46.51% 514.29% -113.46% -89.58% 69.73% -29500.0% -90.91% 120.0%
Net Earnings / Revenue -3.04% -8.4% -0.24% -7.65% -4.03% -2.42% -1.12% -4.12% -17.52% 2.17% -1.74% 2.13% 3.5% 17.58% 8.43% 1.93% -1.68% -3.02% -47.33% 3.55% 8.27% 1.22% -12.71% -163.07% -112.21% 0.82% 9.57% 6.1%
Basic Earnings Per Share -$0.08 -$0.23 -$0.01 -$0.12 -$0.08 -$0.02 -$0.13 -$0.57 $0.07 -$0.06 $0.09 $0.14 $0.66 $0.24
Diluted Earnings Per Share -$0.08 -$0.23 -$7.139K -$202.1K -$0.12 -$0.08 -$0.02 -$0.13 -$0.57 $0.07 -$0.06 $0.08 $0.13 $0.65 $0.24 $54.14K -$44.59K -$73.95K -$1.036M $73.95K $140.1K $25.36K -$201.6K -$6.238M -$5.250M $17.86K $62.86K $48.54K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Cash & Short-Term Investments $4.283M $4.508M $7.821M $8.300M $8.300M $8.200M $5.200M $5.600M $6.700M $14.10M $25.80M $20.70M $17.90M $19.70M $16.60M $13.70M $17.90M $9.400M $7.600M $13.90M $8.200M $15.30M $29.40M $35.80M $2.400M $1.000M
YoY Change -4.99% -42.36% -5.77% 0.0% 1.22% 57.69% -7.14% -16.42% -52.48% -45.35% 24.64% 15.64% -9.14% 18.67% 21.17% -23.46% 90.43% 23.68% -45.32% 69.51% -46.41% -47.96% -17.88% 1391.67% 140.0%
Cash & Equivalents $4.283M $4.508M $7.821M $8.300M $8.300M $8.200M $5.200M $5.600M $6.700M $14.10M $25.80M $20.70M $17.90M $19.70M $16.60M $13.70M $17.90M $9.400M $7.600M $13.90M $8.200M $15.30M $29.40M $35.80M $2.400M $1.000M
Short-Term Investments
Other Short-Term Assets $8.400M $0.00 $0.00 $1.500M $1.500M $1.600M $3.900M $5.400M $600.0K $2.800M $6.700M $19.90M $28.10M $3.500M $2.500M $3.300M $1.800M $1.500M $1.700M $700.0K
YoY Change -100.0% 0.0% -6.25% -58.97% -27.78% 800.0% -78.57% -58.21% -66.33% -29.18% 702.86% 40.0% -24.24% 83.33% 20.0% -11.76% 142.86%
Inventory $24.72M $26.44M $27.59M $22.30M $22.10M $25.10M $16.80M $20.00M $22.30M $20.50M $15.80M $17.80M $18.20M $15.80M $14.40M $11.90M $15.00M $10.70M $9.100M $25.50M $24.70M $15.50M $6.000M $3.700M $2.900M $1.700M
Prepaid Expenses
Receivables $16.10M $16.70M $21.83M $17.80M $20.70M $21.50M $13.40M $15.70M $17.50M $16.10M $13.90M $14.40M $15.10M $15.40M $14.40M $15.10M $14.80M $13.30M $10.10M $18.50M $19.10M $13.90M $6.500M $4.700M $4.200M $1.700M
Other Receivables $3.940M $3.472M $4.341M $3.300M $2.500M $3.100M $3.700M $4.200M $3.900M $4.800M $3.800M $4.600M $2.500M $2.200M $2.200M $0.00 $0.00 $0.00 $0.00 $0.00 $1.300M $500.0K $1.100M $1.200M $200.0K $0.00
Total Short-Term Assets $49.04M $51.12M $61.58M $51.70M $53.60M $57.80M $47.50M $45.50M $50.50M $57.10M $60.80M $59.00M $57.60M $58.60M $48.20M $43.50M $54.30M $53.30M $55.00M $61.30M $55.80M $48.40M $44.80M $46.90M $11.30M $5.100M
YoY Change -4.08% -16.98% 19.12% -3.54% -7.27% 21.68% 4.4% -9.9% -11.56% -6.09% 3.05% 2.43% -1.71% 21.58% 10.8% -19.89% 1.88% -3.09% -10.28% 9.86% 15.29% 8.04% -4.48% 315.04% 121.57%
Property, Plant & Equipment $8.754M $9.182M $10.31M $11.70M $13.20M $5.900M $3.700M $4.300M $5.900M $5.200M $4.400M $4.600M $3.100M $3.100M $3.500M $3.200M $4.500M $4.600M $4.000M $7.100M $6.700M $5.900M $3.500M $1.700M $1.600M $1.000M
YoY Change -4.66% -10.96% -11.86% -11.36% 123.73% 59.46% -13.95% -27.12% 13.46% 18.18% -4.35% 48.39% 0.0% -11.43% 9.38% -28.89% -2.17% 15.0% -43.66% 5.97% 13.56% 68.57% 105.88% 6.25% 60.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.473M $7.780M $5.375M $1.100M $2.300M $1.800M $10.50M $1.300M $1.100M $11.40M $13.40M $11.30M $8.100M $6.500M $1.000M $800.0K $400.0K $900.0K $400.0K $1.500M $1.400M $1.900M $800.0K $500.0K $1.000M $100.0K
YoY Change -16.8% 44.74% 388.64% -52.17% 27.78% -82.86% 707.69% 18.18% -90.35% -14.93% 18.58% 39.51% 24.62% 550.0% 25.0% 100.0% -55.56% 125.0% -73.33% 7.14% -26.32% 137.5% 60.0% -50.0% 900.0%
Total Long-Term Assets $88.33M $94.24M $100.8M $104.6M $111.3M $110.8M $61.90M $62.30M $69.60M $78.80M $74.70M $74.50M $69.00M $66.20M $59.00M $37.80M $44.60M $39.90M $36.60M $78.60M $72.60M $59.20M $37.60M $11.90M $9.300M $2.100M
YoY Change -6.27% -6.48% -3.67% -6.02% 0.45% 79.0% -0.64% -10.49% -11.68% 5.49% 0.27% 7.97% 4.23% 12.2% 56.08% -15.25% 11.78% 9.02% -53.44% 8.26% 22.64% 57.45% 215.97% 27.96% 342.86%
Total Assets $137.4M $145.4M $162.3M $156.3M $164.9M $168.6M $109.4M $107.8M $120.1M $135.9M $135.5M $133.5M $126.6M $124.8M $107.2M $81.30M $98.90M $93.20M $91.60M $139.9M $128.4M $107.6M $82.40M $58.80M $20.60M $7.200M
YoY Change
Accounts Payable $5.554M $6.447M $4.911M $6.000M $5.300M $7.400M $4.400M $6.200M $8.800M $6.300M $4.700M $4.700M $5.000M $4.900M $4.900M $4.700M $5.600M $4.500M $3.400M $6.300M $6.500M $5.500M $3.100M $2.100M $1.900M $800.0K
YoY Change -13.85% 31.28% -18.15% 13.21% -28.38% 68.18% -29.03% -29.55% 39.68% 34.04% 0.0% -6.0% 2.04% 0.0% 4.26% -16.07% 24.44% 32.35% -46.03% -3.08% 18.18% 77.42% 47.62% 10.53% 137.5%
Accrued Expenses $9.381M $8.639M $11.18M $7.600M $2.400M $5.800M $3.800M $4.600M $4.000M $4.500M $5.100M $3.500M $3.300M $4.700M $3.700M $4.000M $4.100M $4.200M $3.100M $4.800M $5.000M $7.400M $2.900M $3.300M $1.400M $600.0K
YoY Change 8.59% -22.69% 47.04% 216.67% -58.62% 52.63% -17.39% 15.0% -11.11% -11.76% 45.71% 6.06% -29.79% 27.03% -7.5% -2.44% -2.38% 35.48% -35.42% -4.0% -32.43% 155.17% -12.12% 135.71% 133.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.400M $2.200M $0.00 $0.00 $0.00 $400.0K $700.0K $3.900M $0.00 $3.000M $1.200M
YoY Change -100.0% -36.36% -100.0% -42.86% -82.05% -100.0% 150.0%
Long-Term Debt Due $5.859M $3.811M $3.235M $1.700M $6.900M $6.000M $2.800M $2.400M $2.400M $5.000M $5.000M
YoY Change 53.74% 17.81% 90.29% -75.36% 15.0% 114.29% 16.67% 0.0% -52.0% 0.0%
Total Short-Term Liabilities $26.54M $23.25M $25.32M $21.10M $25.30M $25.50M $14.00M $14.60M $19.30M $18.10M $16.10M $9.900M $9.600M $11.30M $12.30M $11.20M $16.30M $14.70M $13.00M $16.10M $15.60M $16.60M $12.20M $6.400M $7.500M $2.800M
YoY Change 14.16% -8.16% 19.98% -16.6% -0.78% 82.14% -4.11% -24.35% 6.63% 12.42% 62.63% 3.13% -15.04% -8.13% 9.82% -31.29% 10.88% 13.08% -19.25% 3.21% -6.02% 36.07% 90.63% -14.67% 167.86%
Long-Term Debt $30.70M $43.01M $45.10M $46.30M $46.90M $54.80M $9.000M $11.40M $16.40M $16.50M $19.80M $13.00M $16.30M $18.00M $13.30M $100.0K $5.600M $3.000M $8.500M $16.50M $12.80M $400.0K $600.0K $0.00 $5.100M $600.0K
YoY Change -28.62% -4.62% -2.6% -1.28% -14.42% 508.89% -21.05% -30.49% -0.61% -16.67% 52.31% -20.25% -9.44% 35.34% 13200.0% -98.21% 86.67% -64.71% -48.48% 28.91% 3100.0% -33.33% -100.0% 750.0%
Other Long-Term Liabilities $6.270M $6.288M $6.974M $10.30M $9.000M $3.300M $2.800M $3.200M $3.000M $4.600M $5.000M $6.100M $4.900M $4.300M $4.400M $2.100M $1.200M $2.300M $900.0K $1.400M $1.000M $1.300M
YoY Change -0.29% -9.84% -32.29% 14.44% 172.73% 17.86% -12.5% 6.67% -34.78% -8.0% -18.03% 24.49% 13.95% -2.27% 109.52% 75.0% -47.83% 155.56% -35.71% 40.0% -23.08%
Total Long-Term Liabilities $36.97M $49.30M $52.07M $56.60M $55.90M $58.10M $11.80M $14.60M $19.40M $21.10M $24.80M $19.10M $21.20M $22.30M $17.70M $2.200M $6.800M $5.300M $9.400M $17.90M $13.80M $1.700M $600.0K $0.00 $5.100M $600.0K
YoY Change -25.0% -5.32% -8.01% 1.25% -3.79% 392.37% -19.18% -24.74% -8.06% -14.92% 29.84% -9.91% -4.93% 25.99% 704.55% -67.65% 28.3% -43.62% -47.49% 29.71% 711.76% 183.33% -100.0% 750.0%
Total Liabilities $64.29M $73.14M $78.94M $79.60M $83.20M $85.90M $28.50M $35.60M $42.50M $40.40M $41.00M $29.30M $31.10M $34.50M $32.00M $14.60M $24.70M $21.30M $23.20M $35.50M $29.60M $19.20M $15.50M $6.500M $12.60M $3.500M
YoY Change -12.1% -7.35% -0.83% -4.33% -3.14% 201.4% -19.94% -16.24% 5.2% -1.46% 39.93% -5.79% -9.86% 7.81% 119.18% -40.89% 15.96% -8.19% -34.65% 19.93% 54.17% 23.87% 138.46% -48.41% 260.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $98.574 Million

About HARVARD BIOSCIENCE INC

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. The company is headquartered in Holliston, Massachusetts and currently employs 391 full-time employees. The company went IPO on 2013-10-21. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.

Industry: Laboratory Analytical Instruments Peers: Alpha Teknova, Inc. CHAMPIONS ONCOLOGY, INC. ChromaDex Corp. STANDARD BIOTOOLS INC. IsoPlexis Corp Miromatrix Medical Inc. Personalis, Inc. RAPID MICRO BIOSYSTEMS, INC. Singular Genomics Systems, Inc. THERMO FISHER SCIENTIFIC INC.